1. World Health Organization (WHO). Osteoporosis: both health organizations and individuals must act now to avoid an impending epidemic [Internet]. 1999. cited 2015 Mar 15. Available from:
http://www.who.int/inf-pr-1999/en/pr99-58.html.
2. Cooper C, Campion G, Melton LJ 3rd. Hip fractures in the elderly: a world-wide projection. Osteoporos Int. 1992; 2:285–289.
Article
3. Ray NF, Chan JK, Thamer M, Melton LJ 3rd. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997; 12:24–35.
Article
5. Park C, Jang S, Jang S, et al. Identification and validation of osteoporotic hip fracture using the national health insurance database. J Korean Hip Soc. 2010; 22:305–311.
Article
6. Ha YC, Kim SR, Koo KH, et al. An epidemiological study of hip fracture in Jeju Island, Korea. J Korean Orthop Assoc. 2004; 39:131–136.
Article
7. Lim S, Koo BK, Lee EJ, et al. Incidence of hip fractures in Korea. J Bone Miner Metab. 2008; 26:400–405.
Article
8. Choi HJ, Shin CS, Ha YC, et al. Burden of osteoporosis in adults in Korea: a National Health Insurance Database study. J Bone Miner Metab. 2012; 30:54–58.
Article
9. Gong HS, Oh WS, Chung MS, Oh JH, Lee YH, Baek GH. Patients with wrist fractures are less likely to be evaluated and managed for osteoporosis. J Bone Joint Surg Am. 2009; 91:2376–2380.
Article
10. Guañabens N, Peris P, Monegal A, Pons F, Collado A, Muñoz-Gómez J. Lower extremity stress fractures during intermittent cyclical etidronate treatment for osteoporosis. Calcif Tissue Int. 1994; 54:431–434.
Article
11. Armamento-Villareal R, Napoli N, Diemer K, et al. Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series. Calcif Tissue Int. 2009; 85:37–44.
Article
12. Goh SK, Yang KY, Koh JS, et al. Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution. J Bone Joint Surg Br. 2007; 89:349–353.
13. Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital. Drug Saf. 2009; 32:775–785.
14. Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008; 39:224–231.
Article
15. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17:1726–1733.
Article
16. Rowe SM, Yoon TR, Ryang DH. An epidemiological study of hip fracture in Honam, Korea. Int Orthop. 1993; 17:139–143.
Article
17. Shin HH, Kim SY, Sohn SJ. Estimation of incidence rate of osteoporotic fracture among the elderly in a city. Korean J Bone Metab. 2001; 8:159–171.
18. Rowe SM, Song EK, Kim JS, et al. Rising incidence of hip fracture in Gwangju City and Chonnam Province, Korea. J Korean Med Sci. 2005; 20:655–658.
Article
19. Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int. 2001; 12:417–427.
Article
20. Dhanwal DK, Dennison EM, Harvey NC, Cooper C. Epidemiology of hip fracture: Worldwide geographic variation. Indian J Orthop. 2011; 45:15–22.
Article
21. Schwartz AV, Kelsey JL, Maggi S, et al. International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on Aging. Osteoporos Int. 1999; 9:242–253.
Article
22. Hiligsmann M, Bruyère O, Roberfroid D, et al. Trends in hip fracture incidence and in the prescription of antiosteoporosis medications during the same time period in Belgium (2000-2007). Arthritis Care Res (Hoboken). 2012; 64:744–750.
Article
23. Abrahamsen B, Vestergaard P. Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int. 2010; 21:373–380.
Article
24. Leslie WD, Sadatsafavi M, Lix LM, et al. Secular decreases in fracture rates 1986-2006 for Manitoba, Canada: a population-based analysis. Osteoporos Int. 2011; 22:2137–2143.
Article
25. Adams AL, Shi J, Takayanagi M, Dell RM, Funahashi TT, Jacobsen SJ. Ten-year hip fracture incidence rate trends in a large California population, 1997-2006. Osteoporos Int. 2013; 24:373–376.
Article
26. Crisp A, Dixon T, Jones G, et al. Declining incidence of osteoporotic hip fracture in Australia. Arch Osteoporos. 2012; 7:179–185.
Article